publication venue for
- Challenges of treating mantle cell lymphoma in older adults.. 66:433-450. 2024
- High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy.. 65:1-1023. 2024
- Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.. 65:1-4. 2024
- Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms.. 64:2347-2350. 2023
- Baseline correlates of frailty and its association with survival in United States veterans with acute myeloid leukemia.. 64:1-10. 2023
- WT1. 64:1-11. 2023
- EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.. 64:1026-1034. 2023
- Comorbidity burden and outcomes of older adults with acute promyelocytic leukemia: a National Cancer Database analysis of 2221 patients.. 64:691-697. 2023
- Impact of diet and antibiotics on gut microbiota and outcomes in patients with multiple myeloma treated with autologous hematopoietic stem cell transplantation.. 64:1-2. 2022
- Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma.. 64:407-414. 2022
- Longitudinal assessment of quality of life in indolent non-Hodgkin lymphomas managed with active surveillance.. 63:1-3339. 2022
- Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML).. 63:1-3236. 2022
- Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia.. 63:1645-1650. 2022
- Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide.. 63:1925-1933. 2022
- Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation.. 63:1-1226. 2021
- Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma.. 62:1003-1006. 2020
- Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists.. 62:387-398. 2020
- Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation.. 61:2200-2207. 2020
- The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients.. 61:1833-1841. 2020
- HIV portends a poor prognosis in myelodysplastic syndromes.. 60:3529-3535. 2019
- Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation.. 60:3569-3572. 2019
- Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation - a single institution pilot study.. 60:3308-3311. 2019
- Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.. 60:1693-1696. 2019
- Most multiple myeloma patients have low testosterone.. 60:836-838. 2018
- Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products.. 59:2829-2835. 2018
- Emerging molecular predictive and prognostic factors in acute myeloid leukemia.. 59:2021-2039. 2017
- Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.. 59:888-895. 2017
- Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide.. 59:743-745. 2017
- Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States.. 58:982-985. 2016
- Vancomycin-resistant enterococci infection: not just for the transplanted.. 55:1320-5. 2013
- Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma.. 54:1658-64. 2012
- Salvage chemotherapy and autologous hematopoietic cell transplant in primary refractory diffuse large B-cell lymphoma: progress or better patient selection?. 53:756-7. 2012
- Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy 2024